Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
09/1995
09/08/1995WO1995023859A2 Novel forms of t cells costimulatory molecules and uses therefor
09/08/1995WO1995023857A1 Yeast strains and modified albumins
09/08/1995WO1995023856A1 Chimeric complement inhibitor proteins
09/08/1995WO1995023855A2 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
09/08/1995WO1995023847A1 Monoclonal antibody to bacillus thuringiensis delta-endotoxin in an inactive form and its use
09/08/1995WO1995023813A1 In vitro antibody affinity maturation using alanine scanning mutagenesis
09/08/1995WO1995023812A1 Antibiotic stalobacins
09/08/1995WO1995023611A1 Products comprising substrates capable of enzymatic cross-linking
09/08/1995WO1995023512A1 Terminal complement inhibitor fusion genes and proteins
09/08/1995WO1995014099A3 Process for protein production in plants
09/08/1995CA2184580A1 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
09/08/1995CA2184356A1 Terminal complement inhibitor fusion genes and proteins
09/08/1995CA2184355A1 Chimeric complement inhibitor proteins
09/08/1995CA2184277A1 Novel forms of t cells costimulatory molecules and uses therefor
09/08/1995CA2184058A1 Kunitz domain inhibitor proteins derived from alzheimer's amyloid .beta.-protein precursor inhibitor
09/08/1995CA2183951A1 Antibiotic stalobacins
09/08/1995CA2183643A1 Products comprising substrates capable of enzymatic cross-linking
09/08/1995CA2183550A1 In vitro antibody affinity maturation using alanine scanning mutagenesis
09/08/1995CA2181787A1 Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders
09/06/1995EP0670369A2 A novel peptide related to human programmed cell death and DNA encoding it
09/06/1995EP0670332A2 Protein complexes having factor VIII:C activity and production thereof
09/06/1995EP0669988A1 Angiogenesis inhibitory antibodies
09/06/1995EP0669987A1 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain
09/06/1995EP0669985A1 Conjugate vaccine against group b streptococcus
09/06/1995EP0669983A1 Allergenic proteins and peptides from japanese cedar pollen
09/06/1995EP0669982A1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins
09/06/1995EP0669981A1 Interferon tau compositions and methods of use
09/06/1995EP0669980A1 Method of controlling polypeptide production in bacteria
09/06/1995EP0669979A1 C-c ckr-1, c-c chemokine receptor
09/06/1995EP0669978A1 Flk-1 is a receptor for vascular endothelial growth factor
09/06/1995EP0669976A1 Transcription factor dp-1
09/06/1995EP0669939A1 Somatotropin modifications
09/06/1995EP0669934A1 Process for manufacturing crystals of growth hormone and crystals thereby obtained
09/06/1995EP0669933A1 PURIFICATION OF FUSION PROTEINS COMPRISING GM-CSF and IL-3
09/06/1995EP0669930A1 Cellular genes encoding retinoblastoma-associated proteins
09/06/1995EP0669929A1 Novel cytokine designated elk ligand
09/06/1995EP0669925A1 Aids therapeutics based on hiv ma peptides
09/06/1995EP0669829A1 Enhancement of xenograft tolerance and porcine cytokines therefor
09/06/1995EP0590059A4 Production and recovery of recombinant neurotrophins
09/06/1995EP0548175B1 Transcription initiation regulating nucleotide sequence
09/06/1995EP0529010B1 Mammalian cells expressing a hybrid receptor
09/06/1995EP0474797B1 Protein having a transactivating property, vectors expressing this protein, cell lines, and uses thereof
09/06/1995EP0449923B1 In vivo recombination process for partially homologous dna sequences
09/06/1995EP0317627B1 Oncogene-encoded polypeptide having growth factor activity and methods of production and use thereof
09/06/1995CN1107887A Methods for producing protein C
09/05/1995US5447913 Therapeutic uses of bactericidal/permeability-increasing protein dimer products
09/05/1995US5447861 Continuous mammalian cell lines having monocyte/macrophage characteristics and their establishment in vitro
09/05/1995US5447858 Heat resistance, plants
09/05/1995US5447854 Production of cyclosporin A and/or C with a strain of NECTRIA
09/05/1995US5447853 Culture and separation of cells
09/05/1995US5447852 DNA encoding cyclophilin C, and recombinant methods employing it
09/05/1995CA1336896C Process for extracting and purifying epidermin
09/05/1995CA1336887C Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
08/1995
08/31/1995WO1995023234A1 Isolated, tyrosinase derived peptides and uses thereof
08/31/1995WO1995023233A1 Method for carbohydrate engineering of glycoproteins
08/31/1995WO1995023223A1 Dna encoding the vertebrate homolog of hedgehog, vhh-1, expressed by the notochord, and uses thereof
08/31/1995WO1995023214A1 Method for stimulating profileration of colon cells using pomc¿76-103?
08/31/1995WO1995023166A1 Synthetic inverso or retro-inverso t-cell epitopes
08/31/1995WO1995023159A1 Novel bombesin-related peptides
08/31/1995WO1995022988A1 Vacuolating toxin-deficient h. pylori and related methods
08/31/1995WO1995022986A1 Fibrin-specific antibody for use as an antithrombotic agent
08/31/1995WO1995022980A1 Inhibin compositions and methods of use thereof
08/31/1995WO1995022978A1 Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament
08/31/1995WO1995022977A1 Antigen-based heteropolymers and method for treating autoimmune diseases using the same
08/31/1995WO1995016036A3 IFN-ηRECEPTOR β-CHAIN AND DERIVATIVES THEREOF
08/31/1995CA2184176A1 Method for stimulating profileration of colon cells using pomc76-103
08/31/1995CA2184092A1 Dna encoding the vertebrate homolog of hedgehog, vhh-1, expressed by the notochord, and uses thereof
08/31/1995CA2183977A1 Synthetic inverso or retro-inverso t-cell epitopes
08/31/1995CA2183953A1 Fibrin-specific antibody for use as an antithrombotic agent
08/31/1995CA2183769A1 Vacuolating toxin-deficient h. pylori and related methods
08/31/1995CA2183556A1 Novel bombesin-related peptides
08/31/1995CA2183535A1 Antigen-based heteropolymers and method for treating autoimmune diseases using the same
08/30/1995EP0669397A1 Novel protein and gene coding for the same
08/30/1995EP0669344A2 Monoclonal antibody and immunoassay using the same
08/30/1995EP0669343A1 Cyclic depsipeptides containing lactic acid with 18 ring atoms as endoparasiticidal agents and process for their preparation
08/30/1995EP0669133A1 Paramunity inducer based ou combinations of poxvirus components, process to prepore it and its use as medicament
08/30/1995EP0668933A1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy
08/30/1995EP0668930A1 A method of identifying ligands and antagonists of ligands
08/30/1995EP0668924A1 HUMANIZED ANTIBODIES TO Fc RECEPTORS FOR IMMUNOGLOBULIN G ON HUMAN MONONUCLEAR PHAGOCYTES
08/30/1995EP0668923A1 Monoclonal antibody
08/30/1995EP0668918A1 Disease associated human autoantibodies specific for human thyroid peroxidase
08/30/1995EP0668916A1 Haemophilus outer membrane protein
08/30/1995EP0668915A1 Protein allergens of the species cynodon dactylon
08/30/1995EP0668914A1 Crystallization of m-csf
08/30/1995EP0668913A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle
08/30/1995EP0668912A1 THE St-B17 SEROTONIN RECEPTOR
08/30/1995EP0668911A1 Synthesis and purification of truncated and mutein forms of human ciliary neuronotrophic factor
08/30/1995EP0668910A1 Human neuropeptide y-y1 receptor
08/30/1995EP0668909A1 Transgenic, cross-linked hemoglobin
08/30/1995EP0668906A1 Method for producing polypeptide via bacterial fermentation
08/30/1995EP0668879A1 Truncated insulin-like growth factor binding proteins having mitogenic activity
08/30/1995EP0668871A1 Amino-acid sequence homologies between selectins and b. pertussis toxin-peptidesderived therfrom, antibodies thereto and pharmaceutical compositions
08/30/1995EP0668779A1 COMPOSITION PROTECTIVE AGAINST $i(P. MULTOCIDA) PASTEURELLOSIS INFECTION
08/30/1995EP0668777A1 Prostate-specific membrane antigen
08/30/1995EP0668725A1 Method of preparing protein hydrolysates low in chromium.
08/30/1995EP0518999B1 Protein hydrolysates
08/30/1995EP0485577B1 Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae
08/30/1995EP0469025B1 Improvements in or relating to enhancers
08/30/1995CN1107513A Method of producing peptides, recombinant plasmid for use in the same and animal cells transformed with the same
08/30/1995CN1107335A Enzymolytic pearl liquor
1 ... 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 ... 1125